DK0579833T3 - Ethanolaminderivater med anti-pollakisuria-virkning - Google Patents

Ethanolaminderivater med anti-pollakisuria-virkning

Info

Publication number
DK0579833T3
DK0579833T3 DK92908496.0T DK92908496T DK0579833T3 DK 0579833 T3 DK0579833 T3 DK 0579833T3 DK 92908496 T DK92908496 T DK 92908496T DK 0579833 T3 DK0579833 T3 DK 0579833T3
Authority
DK
Denmark
Prior art keywords
hydrogen
lower alkyl
halogen
hydroxy
pollakisuria
Prior art date
Application number
DK92908496.0T
Other languages
English (en)
Inventor
Youichi Shiokawa
Masanobu Nagano
Kiyoshi Taniguchi
Kazuhiko Take
Takeshi Kato
Kazunori Tsubaki
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK0579833T3 publication Critical patent/DK0579833T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK92908496.0T 1991-04-12 1992-04-10 Ethanolaminderivater med anti-pollakisuria-virkning DK0579833T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919107827A GB9107827D0 (en) 1991-04-12 1991-04-12 New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
DK0579833T3 true DK0579833T3 (da) 1997-09-15

Family

ID=10693176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92908496.0T DK0579833T3 (da) 1991-04-12 1992-04-10 Ethanolaminderivater med anti-pollakisuria-virkning

Country Status (7)

Country Link
EP (1) EP0579833B1 (da)
JP (1) JP3158436B2 (da)
AT (1) ATE157080T1 (da)
DE (1) DE69221721D1 (da)
DK (1) DK0579833T3 (da)
GB (1) GB9107827D0 (da)
WO (1) WO1992018461A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US6197993B1 (en) 1996-07-02 2001-03-06 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient
JP3909864B2 (ja) * 1995-07-26 2007-04-25 小野薬品工業株式会社 ナフチルオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6075040A (en) * 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
CZ126598A3 (cs) * 1995-10-26 1998-09-16 Mitsubishi-Tokyo Pharmaceuticals, Inc. Fenylethanolaminové sloučeniny, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
TW375604B (en) * 1996-02-19 1999-12-01 Kissei Pharmaceutical 3,4-di-substituting phenyl-ethanolamine-tetrahydronaphthyl carboxylic amide derivatives
JP3708624B2 (ja) * 1996-03-27 2005-10-19 キッセイ薬品工業株式会社 ３，４−ジ置換フェニルエタノールアミノテトラリンカルボン酸誘導体
SG55296A1 (en) * 1996-04-12 1998-12-21 Kissei Pharmaceutical Phenylethalolaminotetralincarboxamide derivatives
KR100786315B1 (ko) * 1996-04-12 2008-03-14 깃세이 야쿠힌 고교 가부시키가이샤 페닐에탄올아미노테트랄린카르복실산아미드유도체
JP4685201B2 (ja) * 1996-08-19 2011-05-18 キッセイ薬品工業株式会社 頻尿および尿失禁の予防・治療剤
EP0827746B1 (en) * 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
AUPO565997A0 (en) * 1997-03-17 1997-04-10 Fujisawa Pharmaceutical Co., Ltd. Propanolamine derivatives
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
US6699338B2 (en) 1999-04-08 2004-03-02 Jfe Steel Corporation Method of manufacturing corrosion resistant steel materials
EP1483236A1 (en) * 2002-03-14 2004-12-08 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
JP3815496B2 (ja) 2002-11-07 2006-08-30 アステラス製薬株式会社 酢酸アニリド誘導体を有効成分とする過活動膀胱治療剤
CN101220118B (zh) * 2007-01-12 2010-08-11 远东新世纪股份有限公司 改质共聚物及以其改质的鞘层材料及芯鞘型复合纤维
WO2011126967A1 (en) * 2010-04-08 2011-10-13 Medicinova, Inc. Methods and compositions for the treatment of irritable bowel syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
US4927955A (en) * 1987-08-12 1990-05-22 Sanofi Process for the O-alkylation of N-(hydroxy)aralkylphenylethanolamines
DE3872100T2 (de) * 1987-08-12 1993-01-28 Sanofi Elf Verfahren zur herstellung von phenylaethanolaminotetralinen.
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
DE69028877T2 (de) * 1989-06-13 1997-02-27 Sanofi Sa Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden

Also Published As

Publication number Publication date
JP3158436B2 (ja) 2001-04-23
EP0579833B1 (en) 1997-08-20
ATE157080T1 (de) 1997-09-15
EP0579833A1 (en) 1994-01-26
WO1992018461A1 (en) 1992-10-29
GB9107827D0 (en) 1991-05-29
DE69221721D1 (de) 1997-09-25
JPH06506676A (ja) 1994-07-28

Similar Documents

Publication Publication Date Title
DK0579833T3 (da) Ethanolaminderivater med anti-pollakisuria-virkning
GR3032311T3 (en) Stilbene derivatives and pharmaceutical compositions containing them
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MX9204008A (es) Derivados de metilen-oxindol y proceso para su preparacion.
MX9504349A (es) Derivados de aroilpiperidina.
IL104567A (en) Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO1999024022A3 (en) Isoquinoline derivatives for treating disorders associated with 5ht7 receptors
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
IE901883L (en) Antispasmodic agents
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
DE69330601D1 (de) Serotoninergische ergolin derivate
DK0648202T3 (da) Substituerede (arylalkylaminobenzyl)aminopropanamidderivater, fremstilling deraf og anvendelse som anti-epileptiske, neurobeskyttende og antidepressive midler
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
ATE124946T1 (de) Neuro-schützende mittel.
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
NO941478L (no) Ny forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse
ES2084485T3 (es) Procedimiento para la preparacion de amino-2 nitro-7 benzotiazoles.
GR3020922T3 (en) Amide derivatives of 1-amino-octahydropyrido[2,1-c][1,4]oxazine, processes for their preparation and pharmaceutical compositions containing them